欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号RO/V/0001/001
药品名称Parvoerysin
活性成分
    • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated 1.0 RP
    • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated 1.0 RP
    • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated 1.0 RP
    • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated 1.0 RP
    • Porcine parvovirus, strain CAPM V198 S-27, Inactivated 4.0 log2
剂型Emulsion for injection
上市许可持有人Bioveta a.s.
参考成员国 - 产品名称Romania (RO)
PARVOERYSIN
互认成员国 - 产品名称
    • Italy (IT)
      Parvoerysin
    • Lithuania (LT)
      Parvoerysin
    • Estonia (EE)
      Parvoerysin
    • Slovakia (SK)
      Parvoerysin
许可日期2025/08/28
最近更新日期2025/08/28
药物ATC编码
    • QI09AL01 porcine parvovirus + erysipelothrix
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase